Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Interest & Investment Income (2018 - 2025)

Historic Interest & Investment Income for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $2.7 million.

  • Neurogene's Interest & Investment Income rose 4869.71% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.1 million, marking a year-over-year increase of 5968.76%. This contributed to the annual value of $8.5 million for FY2024, which is 18691.97% up from last year.
  • Latest data reveals that Neurogene reported Interest & Investment Income of $2.7 million as of Q3 2025, which was up 4869.71% from $2.9 million recorded in Q2 2025.
  • In the past 5 years, Neurogene's Interest & Investment Income ranged from a high of $3.2 million in Q1 2025 and a low of $650000.0 during Q3 2023
  • In the last 3 years, Neurogene's Interest & Investment Income had a median value of $2.0 million in 2024 and averaged $1.8 million.
  • As far as peak fluctuations go, Neurogene's Interest & Investment Income surged by 19858.43% in 2024, and later soared by 3818.97% in 2025.
  • Neurogene's Interest & Investment Income (Quarter) stood at $781000.0 in 2023, then skyrocketed by 190.65% to $2.3 million in 2024, then grew by 20.66% to $2.7 million in 2025.
  • Its Interest & Investment Income stands at $2.7 million for Q3 2025, versus $2.9 million for Q2 2025 and $3.2 million for Q1 2025.